Correlation Between Entera Bio and Adial Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Entera Bio and Adial Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entera Bio and Adial Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entera Bio and Adial Pharmaceuticals WT, you can compare the effects of market volatilities on Entera Bio and Adial Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entera Bio with a short position of Adial Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entera Bio and Adial Pharmaceuticals.
Diversification Opportunities for Entera Bio and Adial Pharmaceuticals
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Entera and Adial is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Entera Bio and Adial Pharmaceuticals WT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adial Pharmaceuticals and Entera Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entera Bio are associated (or correlated) with Adial Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adial Pharmaceuticals has no effect on the direction of Entera Bio i.e., Entera Bio and Adial Pharmaceuticals go up and down completely randomly.
Pair Corralation between Entera Bio and Adial Pharmaceuticals
If you would invest 0.61 in Adial Pharmaceuticals WT on August 30, 2024 and sell it today you would earn a total of 0.00 from holding Adial Pharmaceuticals WT or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Entera Bio vs. Adial Pharmaceuticals WT
Performance |
Timeline |
Entera Bio |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Adial Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Entera Bio and Adial Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Entera Bio and Adial Pharmaceuticals
The main advantage of trading using opposite Entera Bio and Adial Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entera Bio position performs unexpectedly, Adial Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adial Pharmaceuticals will offset losses from the drop in Adial Pharmaceuticals' long position.The idea behind Entera Bio and Adial Pharmaceuticals WT pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |